Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

The role of echocardiography and its comparison with NT-proBNP measurements in patients with acute myocardial infarction.

Ranjith N, Pegoraro RJ, Naidoo DP, Kaloo AS, Esterhuizen TM.

Med Sci Monit. 2007 Dec;13(12):CR574-8.

PMID:
18049439
2.

N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.

Puri A, Narain VS, Mehrotra S, Dwivedi SK, Saran RK, Puri VK.

Indian Heart J. 2006 Mar-Apr;58(2):138-43.

PMID:
18989058
3.
4.

[NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].

Swiatkiewicz I, Grubecki A, Koziński M, Fabiszak T, Białoszyński T, Sukiennik A, Kubica J.

Pol Merkur Lekarski. 2006 Mar;20(117):289-92. Polish.

PMID:
16780257
5.

Value of NT-ProBNP level and echocardiographic parameters in ST-segment elevation myocardial infarction treated by primary angioplasty: relationships between these variables and their usefulness as predictors of ventricular remodeling.

López Haldón J, Fernández Quero M, Mancha F, Urbano JA, Guisado A, Villa M, Valle JI, Rodríguez Puras MJ, Ballesteros S, López Pardo F, Díaz de la Llera L, Sánchez González A, Martínez Martínez A.

Rev Esp Cardiol. 2010 Sep;63(9):1019-27. English, Spanish.

6.
7.

NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points.

Luchner A, Hengstenberg C, Löwel H, Buchner S, Schunkert H, Riegger GA, Holmer S.

J Card Fail. 2005 Jun;11(5 Suppl):S21-7.

PMID:
15948096
8.

Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.

Luchner A, Hengstenberg C, Löwel H, Riegger GA, Schunkert H, Holmer S.

Hypertension. 2005 Jul;46(1):118-23. Epub 2005 Jun 6.

9.

N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function.

Luchner A, Hengstenberg C, Löwel H, Trawinski J, Baumann M, Riegger GA, Schunkert H, Holmer S.

Hypertension. 2002 Jan;39(1):99-104.

10.

Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide.

Abhayaratna WP, Marwick TH, Becker NG, Jeffery IM, McGill DA, Smith WT.

Am Heart J. 2006 Nov;152(5):941-8.

PMID:
17070165
11.

Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.

Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ.

J Card Fail. 2000 Jun;6(2):130-9.

PMID:
10908087
12.

Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.

Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, Moschella S, Psaroudaki M, Del Forno D, Orio F, Vitale DF, Chiariello M, Vigorito C.

Eur J Cardiovasc Prev Rehabil. 2008 Feb;15(1):113-8. doi: 10.1097/HJR.0b013e3282f00990.

PMID:
18277196
13.

Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.

David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.

Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. Epub 2007 Dec 18.

PMID:
18089624
15.

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.

Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC Jr.

J Am Coll Cardiol. 2006 Jan 17;47(2):345-53. Epub 2006 Jan 4.

16.

N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.

Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, Stansborough J, Beltrame JF, Selvanayagam JB, Zeitz CJ, Struthers AD, Frenneaux MP, Horowitz JD.

Am J Cardiol. 2011 Nov 1;108(9):1316-21. doi: 10.1016/j.amjcard.2011.06.047. Epub 2011 Aug 24.

PMID:
21871590
17.

N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction.

Kim JY, Lee EY, Jee JH, Lee BW, Chung JH, Jeun ES, Min YK, Lee MS, Kim KW, Lee MK.

Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S238-42. Epub 2007 May 8.

PMID:
17490778
19.

N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.

Dong SJ, de las Fuentes L, Brown AL, Waggoner AD, Ewald GA, Dávila-Román VG.

J Am Soc Echocardiogr. 2006 Aug;19(8):1017-25.

PMID:
16880097

Supplemental Content

Support Center